1. Growth response to magnesium supplementation in pregnant women at risk of intrauterine growth restriction (IUGR)
- Author
-
Elaheh Mesdaghinia, Parastoo Hedayati, Nafiseh Soheilipour, Hamid Reza Gilasi, and Mohadeseh Zarei Yazdeli
- Subjects
intrauterine growth restriction (iugr) ,magnesium ,insulin resistance ,inflammatory factors ,Medicine - Abstract
Background and Aim: Given the significance of intrauterine growth restriction (IUGR) and the unclear mechanisms by which magnesium may prevent it, this study aimed to evaluate the growth response to magnesium supplementation in pregnant women at risk of IUGR in Kashan, Iran. Methods: This double-blind randomized clinical trial involved 70 women identified as being at risk for IUGR through uterine artery Doppler ultrasound. Women between 16 and 30 weeks of gestation were randomly assigned to two groups: one receiving a daily supplement of 250 mg of magnesium (n=35) and the other receiving a placebo (n=35) for a duration of 14 weeks. At the end of the study, biomarkers of oxidative stress (MDA, TAC, and GSH), lipid profile (total cholesterol, LDL-C, HDL-C, and triglycerides), insulin function parameters, inflammatory factors (hs-CRP and nitric oxide), and growth responses were assessed. Results: Daily magnesium supplementation for 14 weeks positively influenced the uterine artery resistance index in women at risk of IUGR. Following the intervention, magnesium supplementation resulted in a significant decrease in serum insulin levels and insulin resistance, alongside a notable increase in insulin sensitivity compared to the placebo group; however, there was no effect on fasting blood sugar levels. The serum levels of triglycerides, total cholesterol, LDL-C, and HDL-C in the magnesium group were comparable to those in the placebo group, showing no significant differences. Additionally, magnesium supplementation led to significant reductions in MDA, TAC, and hs-CRP compared to placebo, while GSH and nitric oxide levels remained similar between both groups with no significant differences. Conclusion: The findings of this study suggest that magnesium supplementation over a 14-week period positively impacts metabolic profiles and intrauterine growth in pregnant women at risk of IUGR.
- Published
- 2024